Lipid lowering does not improve endothelial function in subjects with poorly controlled diabetes.

Diabetes care

Volumn 24, Issue 12, 2001, Pages 2152-2153

  Mansourati, J ^a   Newman, L G ^a   Roman, S H ^a   Travis, A ^a   Rafey, M ^a   Phillips, R A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIMVASTATIN;

ADULT; AGED; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; DIABETES COMPLICATIONS; DIABETES MELLITUS; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; HUMANS; HYPERCHOLESTEROLEMIA; MIDDLE AGED; PLACEBOS; SIMVASTATIN;

EID: 0035653431     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.12.2152     Document Type: Letter

References (0)